Recent studies investigated the dual effect of the SIRT1/FoxO1 axis as tumor promotor or suppressor in different cancers [58], and p53 has emerged as a downstream effector of this axis in BC [58,59,60]. This evidence concerns the gene FOXO1 and breast cancer.